Position in RGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$652,322
+$33,225 QoQ
Shares Held
54,451
-26.3% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 164 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. RGNX ranks #108 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in RGNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $652,322 | 54,451 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $619,097 | 73,878 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $852,465 | 59,199 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $635,539 | 65,859 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $497,977 | 60,655 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $725,236 | 93,821 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $803,964 | 76,641 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,207,323 | 103,190 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,789,818 | 179,868 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,168,952 | 120,833 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,170,300 | 131,853 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,138,190 | 156,988 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,439,673 | 129,015 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,248,841 | 143,247 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,095,138 | 117,107 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,931,367 | 78,193 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,871,281 | 116,640 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,795,292 | 116,064 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,967,055 | 70,779 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,489,896 | 64,090 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,787,093 | 81,709 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $558,336 | 12,309 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,259,480 | 45,766 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $783,374 | 21,270 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||